BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26884185)

  • 1. Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma.
    Lissanu Deribe Y; Shi Y; Rai K; Nezi L; Amin SB; Wu CC; Akdemir KC; Mahdavi M; Peng Q; Chang QE; Hornigold K; Arold ST; Welch HC; Garraway LA; Chin L
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1296-305. PubMed ID: 26884185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between PREX2 mutations and the PI3K pathway and its effect on epigenetic regulation of gene expression in NRAS-mutant melanoma.
    Lissanu Deribe Y
    Small GTPases; 2016 Jul; 7(3):178-85. PubMed ID: 27111337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent.
    Ko H; Ahn HJ; Kim YI
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion.
    Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R
    Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
    Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
    Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21-activated Kinases (PAKs) Mediate the Phosphorylation of PREX2 Protein to Initiate Feedback Inhibition of Rac1 GTPase.
    Barrows D; Schoenfeld SM; Hodakoski C; Silkov A; Honig B; Couvillon A; Shymanets A; Nürnberg B; Asara JM; Parsons R
    J Biol Chem; 2015 Nov; 290(48):28915-31. PubMed ID: 26438819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the role of truncating PREX2 mutations in melanoma.
    Lissanu Deribe Y
    Mol Cell Oncol; 2016 May; 3(3):e1160174. PubMed ID: 27314100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication Study: Melanoma genome sequencing reveals frequent
    Horrigan SK; Courville P; Sampey D; Zhou F; Cai S;
    Elife; 2017 Jan; 6():. PubMed ID: 28100394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma genome sequencing reveals frequent PREX2 mutations.
    Berger MF; Hodis E; Heffernan TP; Deribe YL; Lawrence MS; Protopopov A; Ivanova E; Watson IR; Nickerson E; Ghosh P; Zhang H; Zeid R; Ren X; Cibulskis K; Sivachenko AY; Wagle N; Sucker A; Sougnez C; Onofrio R; Ambrogio L; Auclair D; Fennell T; Carter SL; Drier Y; Stojanov P; Singer MA; Voet D; Jing R; Saksena G; Barretina J; Ramos AH; Pugh TJ; Stransky N; Parkin M; Winckler W; Mahan S; Ardlie K; Baldwin J; Wargo J; Schadendorf D; Meyerson M; Gabriel SB; Golub TR; Wagner SN; Lander ES; Getz G; Chin L; Garraway LA
    Nature; 2012 May; 485(7399):502-6. PubMed ID: 22622578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma.
    Yang MH; Yen CH; Chen YF; Fang CC; Li CH; Lee KJ; Lin YH; Weng CH; Liu TT; Huang SF; Teh BT; Chen YA
    Sci Rep; 2019 Feb; 9(1):2552. PubMed ID: 30796242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
    Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
    J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREX1 Protein Function Is Negatively Regulated Downstream of Receptor Tyrosine Kinase Activation by p21-activated Kinases (PAKs).
    Barrows D; He JZ; Parsons R
    J Biol Chem; 2016 Sep; 291(38):20042-54. PubMed ID: 27481946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREX2 promotes the proliferation, invasion and migration of pancreatic cancer cells by modulating the PI3K signaling pathway.
    Yang J; Gong X; Ouyang L; He W; Xiao R; Tan L
    Oncol Lett; 2016 Aug; 12(2):1139-1143. PubMed ID: 27446408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
    Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
    Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1.
    Ebi H; Costa C; Faber AC; Nishtala M; Kotani H; Juric D; Della Pelle P; Song Y; Yano S; Mino-Kenudson M; Benes CH; Engelman JA
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21124-9. PubMed ID: 24327733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.
    Hodakoski C; Hopkins BD; Barrows D; Mense SM; Keniry M; Anderson KE; Kern PA; Hawkins PT; Stephens LR; Parsons R
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):155-60. PubMed ID: 24367090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
    De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G
    PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Rac Exchanger 2 Protein Facilitates Glioma Progression via Akt and Stat3 Signaling.
    Shang J; Li Y; Yin G; Li Z; Jiang L; Bai Q
    J Mol Neurosci; 2021 Aug; 71(8):1674-1682. PubMed ID: 34322848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MADD is a downstream target of PTEN in triggering apoptosis.
    Jayarama S; Li LC; Ganesh L; Mardi D; Kanteti P; Hay N; Li P; Prabhakar BS
    J Cell Biochem; 2014 Feb; 115(2):261-70. PubMed ID: 24038283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.
    Fine B; Hodakoski C; Koujak S; Su T; Saal LH; Maurer M; Hopkins B; Keniry M; Sulis ML; Mense S; Hibshoosh H; Parsons R
    Science; 2009 Sep; 325(5945):1261-5. PubMed ID: 19729658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.